Taylor Devices, Inc. carries a market capitalization of 181.70M, placing it among publicly traded companies globally. Its enterprise value stands at 234.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 181.70M |
| Enterprise Value | 234.07M |
Taylor Devices, Inc. currently has 3.22M shares outstanding.
| Shares Outstanding | 3.22M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Taylor Devices, Inc. trades at a trailing price-to-earnings ratio of 26.56. The price-to-sales ratio is 5.71, and the price-to-book ratio stands at 4.10.
| PE Ratio | 26.56 |
| PS Ratio | 5.71 |
| PB Ratio | 4.10 |
| P/TBV Ratio | 3.95 |
| P/FCF Ratio | 22.04 |
| P/OCF Ratio | 30.43 |
On an enterprise value basis, Taylor Devices, Inc. trades at an EV/EBITDA multiple of 19.07 and an EV/FCF ratio of 18.71. The EV/Sales ratio of 4.85 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.19 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.85 |
| EV / EBITDA | 19.07 |
| EV / EBIT | 22.19 |
| EV / FCF | 18.71 |
Taylor Devices, Inc. maintains a current ratio of 11.52, meaning it holds 11.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.52 |
| Quick Ratio | 9.85 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Taylor Devices, Inc. posts a return on equity of 16.98 and a return on invested capital of 14.33.
| Return on Equity (ROE) | 16.98 |
| Return on Assets (ROA) | 15.02 |
| Return on Invested Capital (ROIC) | 14.33 |
| Return on Capital Employed (ROCE) | 16.98 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.27 |
Over the trailing twelve months, Taylor Devices, Inc. has paid 1.79M in income taxes, reflecting an effective tax rate of 14.70.
| Income Tax | 1.79M |
| Effective Tax Rate | 14.70 |
Taylor Devices, Inc.'s stock has gained approximately 21.10062% over the past 52 weeks. The 50-day moving average sits at 54.40, while the 200-day moving average is 59.42.
| Beta (5Y) | N/A |
| 52-Week Price Change | 21.10062% |
| 50-Day Moving Average | 54.40 |
| 200-Day Moving Average | 59.42 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Taylor Devices, Inc. generated 48.26M in revenue and converted that into 10.38M in net income, yielding earnings per share of 3.30. EBITDA reached 12.27M, while operating income came in at 10.55M.
| Revenue | 48.26M |
| Gross Profit | 21.95M |
| Operating Income | 10.55M |
| Pretax Income | 12.18M |
| Net Income | 10.38M |
| EBITDA | 12.27M |
| EBIT | 10.55M |
| Earnings Per Share (EPS) | 3.30 |
Total book value stands at 67.34M, with working capital of 55.80M providing operational flexibility.
| Cash & Cash Equivalents | 41.71M |
| Total Debt | N/A |
| Net Debt | -2.53M |
| Equity (Book Value) | 67.34M |
| Book Value Per Share | 21.43 |
| Working Capital | 55.80M |
Taylor Devices, Inc. produced 9.06M in operating cash flow over the past twelve months. After subtracting -3.45M in capital expenditures, free cash flow totaled 5.61M - equivalent to 1.79 per share.
| Operating Cash Flow | 9.06M |
| Capital Expenditures | -3.45M |
| Free Cash Flow | 5.61M |
| FCF Per Share | 1.79 |
Taylor Devices, Inc. operates with a gross margin of 45.48, reflecting its pricing power and cost economics. The operating margin of 21.86 and net profit margin of 21.52 provide insight into operational efficiency.
| Gross Margin | 45.48 |
| Operating Margin | 21.86 |
| Pretax Margin | 25.23 |
| Profit Margin | 21.52 |
| EBITDA Margin | 25.43 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.24 |
| FCF Yield | 4.54 |
Taylor Devices, Inc.'s most recent stock split took place on December 12, 1988 with a 20:21 split ratio.
| Last Split Date | 12/12/1988 |
| Split Ratio | 20:21 |
Taylor Devices, Inc. posts an Altman Z-Score of 34.43, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 34.43 |